Endoscopic Findings and Clinical Outcomes in Ventricular Assist Device Recipients with Gastrointestinal Bleeding
Open Access
- 27 July 2011
- journal article
- research article
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 56 (11) , 3241-3246
- https://doi.org/10.1007/s10620-011-1828-2
Abstract
Background Gastrointestinal bleeding (GIB) is an important clinical problem in recipients of ventricular assist devices (VAD), although data pertaining to the endoscopic evaluation and management of this complication are limited in the medical literature. Aims We sought to identify the most common endoscopic findings in VAD recipients with GIB, and to better define the diagnostic and therapeutic utility of endosopy for this patient population. Methods Twenty-six subjects with VAD and overt GIB were retrospectively identified. Clinical and endoscopic data were abstracted for each subject on to standardized forms in duplicate and independent fashion. Raw data and descriptive statistics were reported. Results Non-peptic vascular lesions were the most common cause of GIB. A definitive cause of bleeding was identified by endoscopy in almost 60% of subjects. Endoscopic hemostasis was achieved in 14/15 patients in whom bleeding did not stop spontaneously. Rebleeding occurred in 50% of subjects and was successfully retreated or stopped spontaneously in all cases. Colonoscopy did not establish a definitive diagnosis or deliver hemostatic therapy in any case. Conclusions Vascular malformations account for the overwhelming majority of bleeding lesions in VAD patients with GIB. Endoscopy seems to be a safe and effective tool for diagnosing, risk stratifying, and treating this patient population, although multiple endoscopies may be necessary before therapeutic success, and the incidence of rebleeding is high. A prospective multi-center registry is necessary to establish evidence-based management algorithms for VAD recipients with GIB.Keywords
This publication has 14 references indexed in Scilit:
- Severely Impaired von Willebrand Factor-Dependent Platelet Aggregation in Patients With a Continuous-Flow Left Ventricular Assist Device (HeartMate II)Journal of the American College of Cardiology, 2009
- Platelet Dysfunction in Outpatients With Left Ventricular Assist DevicesThe Annals of Thoracic Surgery, 2009
- Gastrointestinal bleeding rates in recipients of nonpulsatile and pulsatile left ventricular assist devicesThe Journal of Thoracic and Cardiovascular Surgery, 2008
- Improved Survival and Decreasing Incidence of Adverse Events With the HeartMate II Left Ventricular Assist Device as Bridge-to-Transplant TherapyThe Annals of Thoracic Surgery, 2008
- Improving outcomes with long-term “destination” therapy using left ventricular assist devicesThe Journal of Thoracic and Cardiovascular Surgery, 2008
- Use of a Continuous-Flow Device in Patients Awaiting Heart TransplantationNew England Journal of Medicine, 2007
- Gastrointestinal bleeding from arteriovenous malformations in patients supported by the Jarvik 2000 axial-flow left ventricular assist deviceThe Journal of Heart and Lung Transplantation, 2005
- Aortic stenosis and bleeding gastrointestinal angiodysplasia: is acquired von Willebrand's disease the link?The Lancet, 1992
- Cessation of Recurrent Bleeding from Gastrointestinal Angiodysplasias After Aortic Valve ReplacementAnnals of Internal Medicine, 1986
- Use of a Prosthetic Ventricle as a Bridge to Cardiac Transplantation for Postinfarction Cardiogenic ShockNew England Journal of Medicine, 1986